Loading company…
MicroBiopharm Japan provides biopharmaceutical research and contract manufacturing services.
MicroBiopharm Japan focuses on regenerative medicine, including cell and gene therapies. Its customers include pharmaceutical companies, hospitals and research institutions. Founded in 2011 and based in Tokyo, Japan, it was acquired by T Capital Partners on July 2, 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in